Clinical Trial Detail

NCT ID NCT02375672
Title Study of Pembrolizumab in Combination With Chemotherapy for Patients With Advanced Colorectal Cancer
Recruitment Active, not recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Safi Shadha, M.D.
Indications

colorectal adenocarcinoma

Therapies

Pembrolizumab

Fluorouracil + Leucovorin + Oxaliplatin + Pembrolizumab

Age Groups: adult

No variant requirements are available.